$26.72
-0.18-0.67%
Last update: Aug 18, 9:29 AM
NewAmsterdam Pharma Co NV
NAMSNASDAQ
NewAmsterdam Pharma Co Earnings & Forecasts
NewAmsterdam Pharma Co (NAMS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NewAmsterdam Pharma Co Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.43 | $-0.43 | $-0.38 | $-0.36 |
| Actual | $-0.52 | $-0.40 | $-0.63 | $-0.61 |
| Surprise | -20.9% | +6.98% | -65.8% | -69.4% |
| Revenue | ||||
| Estimate | $2.4M | $1.2M | $4.3M | $4.3M |
| Actual | $3.7M | $3.0M | $32000 | $348000 |
| Surprise | +53.2% | +155.4% | -99.3% | -91.9% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.46 | $-0.39 | $-0.57 | $-0.61 |
| Revenue | ||||
| Consensus | $7.4M | $16.4M | — | — |
